Search | DIAL.pr - BOREAL

Accès à distance ? S'identifier sur le proxy UCLouvain

Displaying 1 result.

- Speech
REGINA: A phase II trial of neoadjuvant regorafenib (Rego) in combination with nivolumab (Nivo) and short-course radiotherapy (SCRT) in intermediate-risk, stage II-III rectal cancer (RC).
Bregni, Giacomo Senti, Chiara Acedo Reina, Elena Gkolfakis, Paraskevas Moretti, Luigi Veron, Ana Demetter, Pieter Liberale, Gabriel Carrasco, Javier Geboes, Karen Paula Gokburun, Yeter Peeters, Marc Van den Eynde, Marc[UCL] Van Laethem, Jean-Luc Vergauwe, Philippe Buyse, Marc E. Deleporte, Amélie Hendlisz, Alain Sclafani, Francesco (2022) 2022 ASCO Gastrointestinal Cancers Symposium —